6th Jul 2015 14:27
TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:
Spire Healthcare Group plc
2. Reason for the notification (please state Yes/No):
An acquisition or disposal of voting rights:
An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached:
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments: YES
An event changing the breakdown of voting rights: ( )
Other (please specify):
3. Full name of person(s) subject to the notification obligation:
Goldman sachs asset investment management international
4. Full name of shareholder(s) (if different from 3.):
5. Date of the transaction (and date on which the threshold is crossed or reached if different): 26 June 2015
6. Date on which issuer notified: 30 June 2015
7. Threshold(s) that is/are crossed or reached: Above 5%
8. Notified details: | |||||||
A: Voting rights attached to shares viii, ix | |||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | |||||
NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights x | |||
Direct | Direct xi | Indirect xii | Direct | Indirect | |||
ORDINARY ISIN: GB00BNLPYF73 | Below 5% | Below 5% | 7,672,686 | 7,672,686 | 1.91% | ||
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument | Expiration Date | Exercise/Conversion Period/ Date | Number of voting rights that may be acquired if the instrument is exercised/ converted. | % of voting rights |
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument | Exercise price | Expiration date | Exercise/conversion period | Number of voting rights instruments refers to | % of voting rights | |
Please refer to annexure A |
13,951,828 | Nominal
| Delta 3.48% | |||
Total (A+B+C)
Number of voting rights21,624,514 | % of voting rights5.39% |
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:
N/A
Proxy Voting:
10. Name of the proxy holder: N/A
11. Number of voting rights proxy holder will cease to hold: N/A
12. Date on which proxy holder will cease to hold voting rights: N/A
13. Additional information:
14. Contact name:
Anthony Dand, Interim Deputy Secretary, Spire Healthcare Group plc
15. Contact telephone number:
+ 44 (0)20 7427 9092
Annexure A
Attached to notification of voting rights given in fulfilment of the obligations imposed by the FCA in accordance with DTR5 (including section 5.8.1). by The Goldman Sachs Asset Management International dated 26 June 2015 for itself and its subsidiaries in relation to Spire Healthcare Group plc | |||||
Type of Financial Instrument | Expiration Date | Exercise / Conversion Period/Date | Number of voting rights that may be acquired if the instrument is exercised / converted | % of voting rights that may be obtained if the instrument is exercised/converted | |
Swap | 17-Jan-2020 | 17-Jan-2020 | 13,143,630 | 3.28% | |
Swap | 3-Oct-2019 | 3-Oct-2019 | 808,198 | 0.20% | |
Total Number of voting rights and percentage of voting rights | 13,951,828 | 3.48% | |||
Related Shares:
Spire Healthcare